E

Esperion Therapeutics
D

ESPR

2.49000
USD
0.07
(2.89%)
Pre Open
Volume
256
EPS
-0
Div Yield
-
P/E
-3
Market Cap
488,599,491
Related Instruments
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    289.88 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.85 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.14 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.37 USD
    More
News

Title: Esperion Therapeutics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.